For the Inventor, By the Inventor

Enter assignee name

New Haven, CT, United States of America

Bioxcel Therapeutics, Inc.

USPTO Granted Patents = 17

CIPO Patents = 6

EPO Patents = 3

Trademarks = 5

Forward Citations = 64

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Frank Yocca (17 out of 17 patents)

David Christian Hanley (14 out of 15 patents)

Chetan Dalpatbhai Lathia (14 out of 14 patents)

4. Vasukumar Kakumanu (10 out of 10 patents)

5. Lavanya Rajachandran (8 out of 8 patents)

6. Robert Risinger (8 out of 8 patents)

7. Scott David Barnhart (6 out of 26 patents)

8. Vasukumar Kakumanu (4 out of 4 patents)

9. Krishnan Nandabalan (3 out of 18 patents)

10. Deepa Saini (3 out of 3 patents)

11. Harsh Negi (3 out of 3 patents)

12. Sameer Sharma (3 out of 3 patents)

13. Sameer Sharma (0 patent)

17 patents: Sort by Forward Citations

1. 12364683 - Non-sedating dexmedetomidine treatment regimens (2025-07-22),

2. 12138247 - Non-sedating dexmedetomidine treatment regimens (2024-11-12),

3. 12109196 - Non-sedating dexmedetomidine treatment regimens (2024-10-08),

4. 12090140 - Non-sedating dexmedetomidine treatment regimens (2024-09-17),

5. 11998529 - Non-sedating dexmedetomidine treatment regimens (2024-06-04),

6. 11998528 - Non-sedating dexmedetomidine treatment regimens (2024-06-04),

7. 11931340 - Use of sublingual dexmedetomidine for the treatment of agitation (2024-03-19),

8. 11890272 - Non-sedating dexmedetomidine treatment regimens (2024-02-06),

9. 11839604 - Use of sublingual dexmedetomidine for the treatment of agitation (2023-12-12),

10. 11806429 - Film formulations containing dexmedetomidine and methods of producing them (2023-11-07),

11. 11806334 - Non-sedating dexmedetomidine treatment regimens (2023-11-07),

12. 11786508 - Use of sublingual dexmedetomidine for the treatment of agitation (2023-10-17),

13. 11559484 - Film formulations containing dexmedetomidine and methods of producing them (2023-01-24),

14. 11517524 - Film formulations containing dexmedetomidine and methods of producing them (2022-12-06),

15. 11497711 - Film formulations containing dexmedetomidine and methods of producing them (2022-11-15),

Bioxcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify and develop innovative treatments for neurological disorders and rare diseases. Their proprietary platform, known as BTX-AI, accelerates the discovery and development of novel therapeutics to address unmet medical needs. With a focus on precision medicine, Bioxcel Therapeutics is dedicated to improving patient outcomes and advancing the field of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

17 Patents

#17 in New Haven, CT

#405 in Connecticut

#18,300 in US

#34,819 in the World

New Haven, CT, United States of America

Bioxcel Therapeutics, Inc.

Forward Citations = 64

19 inventors:

Frank Yocca (17 out of 17 patents)

David Christian Hanley (14 out of 15 patents)

Chetan Dalpatbhai Lathia (14 out of 14 patents)

4. Vasukumar Kakumanu (10 out of 10 patents)

5. Lavanya Rajachandran (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…